Company Filing History:
Years Active: 2008
Title: Jessica Kandel: Innovator in Cancer Treatment
Introduction
Jessica Kandel is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods. Her work focuses on improving patient outcomes for those suffering from aggressive forms of cancer.
Latest Patents
Jessica Kandel holds a patent for a groundbreaking method titled "Method of tumor regression with VEGF inhibitors." This patent describes methods of regressing or inhibiting a tumor in a subject by administering an agent capable of blocking, inhibiting, or ameliorating vascular endothelial growth factor (VEGF)-mediated activity. The method results in a reduction of tumor size and inhibition of tumor metastases, making it particularly useful for patients suffering from bulky, metastatic cancers. She has 1 patent to her name.
Career Highlights
Jessica Kandel is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research in oncology. Her work has been instrumental in developing new therapeutic strategies that enhance the effectiveness of cancer treatments.
Collaborations
Jessica collaborates with esteemed colleagues such as Jocelyn Holash and Darrell Yamashiro. Together, they contribute to the innovative research environment at Regeneron Pharmaceuticals.
Conclusion
Jessica Kandel's contributions to cancer treatment through her patented methods highlight her role as a leading inventor in the field. Her dedication to improving patient care continues to inspire advancements in medical research.